MedTrace Logo

The Effect of Melatonin on Nocturnal Enuresis

NCT01575678 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2012-11-02

No results posted yet for this study

Summary

Aim: To investigate the effect of melatonin in bedwetting.

Conditions

  • Nocturnal Enuresis

Interventions

DRUG

Melatonin

blinded capsule 2-4 mg/day, oral use, for 4 weeks

DRUG

Lactose

blinded capsule 1/day, oral use, for 4 weeks

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Søren Rittig, MD, dr.med · Pediatric department, Aarhus Universityhospital, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
6 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01575678 on ClinicalTrials.gov